|
AP1AR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.516400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.129800E-01 |
| Normal-vs-Stage2 |
7.191000E-01 |
| Normal-vs-Stage3 |
8.45110000000648E-05 |
| Normal-vs-Stage4 |
2.21120000087893E-08 |
| Stage1-vs-Stage2 |
7.969800E-01 |
| Stage1-vs-Stage3 |
3.798200E-04 |
| Stage1-vs-Stage4 |
8.04480000393681E-08 |
| Stage2-vs-Stage3 |
5.057700E-02 |
| Stage2-vs-Stage4 |
6.559100E-03 |
| Stage3-vs-Stage4 |
2.438000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.733990E-02 |
| Normal-vs-AfricanAmerican |
4.797500E-04 |
| Normal-vs-Asian |
7.766200E-01 |
| Caucasian-vs-AfricanAmerican |
4.535600E-02 |
| Caucasian-vs-Asian |
8.055000E-01 |
| AfricanAmerican-vs-Asian |
2.660200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.256600E-03 |
| Normal-vs-Female |
1.664220E-01 |
| Male-vs-Female |
3.353400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.597100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.580400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.145000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.743780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.514400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.905840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.555000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.218990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.188000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.316000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.049640E-01 |
| Normal-vs-Grade 2 |
9.523800E-01 |
| Normal-vs-Grade 3 |
2.755400E-03 |
| Normal-vs-Grade 4 |
1.74193992563687E-12 |
| Grade 1-vs-Grade 2 |
2.399400E-01 |
| Grade 1-vs-Grade 3 |
1.966030E-02 |
| Grade 1-vs-Grade 4 |
2.1729999999387E-07 |
| Grade 2-vs-Grade 3 |
9.224300E-03 |
| Grade 2-vs-Grade 4 |
4.21307433384754E-12 |
| Grade 3-vs-Grade 4 |
2.52909999609585E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.123200E-03 |
| Normal-vs-ccB subtype |
1.0106999681625E-09 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.744000E-02 |
| Normal-vs-N1 |
2.10079999999335E-05 |
| N0-vs-N1 |
4.348200E-02 |
|
|
